𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clear cell carcinoma of the ovary with colony-stimulating-factor production. Occurrence of marked granulocytosis in a patient and nude mice

✍ Scribed by Akihiro Takeda; Kenji Suzumori; Yoshie Sugimoto; Yoshiaki Yagami; Takahiko Miyazawa; Chieko Yamada; Mutsushi Matsuyama

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
597 KB
Volume
54
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A case of gastric carcinoma associated w
A case of gastric carcinoma associated with excessive granulocytosis. Production of a colony-stimulating factor by the tumor
✍ Takao Obara; Yukio Ito; Takaya Kodama; Yoshihide Fujimoto; Hideaki Mizoguchi; Ka πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 1013 KB

A patient with gastric carcinoma exhibited an excessive granulocytosis (58,000/pl) preoperatively, in the absence of overt infection. After resection of the primary tumor, the peripheral leukocyte count decreased promptly to the normal value. In a search for a colony-stimulating factor (CSF), the tu

A phase I clinical and pharmacologic stu
A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma
✍ Hiroaki Okamoto; Akira Nagatomo; Hideo Kunitoh; Hiroshi Kunikane; Koshiro Watana πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 3 views

BACKGROUND. This Phase I study was designed to determine the toxicity and efficacy of a carboplatin and irinotecan (CPT-11) regimen with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support for patients with advanced nonsmall cell lung carcinoma. ## METHODS. Treatment consist

Dose escalation study of carboplatin wit
Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma: A study of the lung cancer study group of west Japan
✍ Nobuyuki Katakami; Minoru Takada; Shunichi Negoro; Katsuyasu Ota; Jiro Fujita; K πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 738 KB

## BACKGROUND. We performed a Phase 1-11 trial to determine the maximum tolerated dose of carboplatin (CBDCA) with a fixed dose of VP-16 and granulocyte-colony stimulating factor (G-CSF) in small cell lung cancer (SCLC) patients. ## METHODS. Treatment consisted of a starting dose of CBDCA, 400